Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Benchmark Holdings directors shell out £600,000 on shares

Executive chairman Peter George dipped in for £470,000 and non-exec Yngve Myhre for another £135,240

Two Benchmark Holdings PLC (LON:BMK) directors have shown their confidence in the aquaculture health company, dipping in for £0.6mln worth of shares.

Executive chairman Peter George shelled out £470,000 to buy 1mln shares at a price of 47p apiece.

He completed the purchase on Friday, Benchmark said in a statement on Monday, his first stake in the company.

Yngve Myhre, the Norwegian aquaculture veteran who is a non-executive director of the company, also snapped up £135,240 worth of shares.

He scooped up 225,000 shares at 44.44p and another 75,000 at 46p, to take his total holding to 400,000 shares, or 0.07 of the company’s total share capital.

Last week Benchmark said it was accelerating a programme of disposals and structural efficiencies after discussions with third parties about licensing its non-core animal vaccines were subject to delays.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK